TARO — Taro Pharmaceutical Industries Share News
0.000.00%
Last trade - 00:00HealthcareBalancedMid Cap
- $1.62bn
- $735.77m
- $629.18m
Taro Pharmaceutical Industries Ltd reports results for the quarter ended in September - Earnings Summary
Brief: Taro posts Q2 sales USD 148.202 million
Taro Pharmaceutical Industries Ltd expected to post earnings of 18 cents a share - Earnings Preview
Taro Pharmaceutical Industries Ltd reports results for the quarter ended in June - Earnings Summary
Taro Pharmaceutical Industries Ltd expected to post earnings of 31 cents a share - Earnings Preview
Brief: Krensavage Asset Management Says Opposes Sun Pharmaceutical Industries Ltd.'S Bid To Take Taro Pharmaceutical Industries Private
India's Sun Pharma gains after Macquarie reiterates "buy" rating
Taro Pharmaceutical Industries Ltd reports results for the quarter ended in March - Earnings Summary
Brief: Taro Says Q4 Earnings Per Share $0.18
Taro Pharmaceutical Industries Ltd expected to post earnings of 19 cents a share - Earnings Preview
Brief: Taro Pharmaceutical Says Its Business Operations Is Impacted Due To Sun's Cybersecurity Incident
Brief: Taro Provides Results For Dec 31 2022
Taro Pharmaceutical Industries Ltd expected to post earnings of 87cents a share - Earnings Preview
Taro Pharmaceutical Industries Ltd reports results for the quarter ended in September - Earnings Summary
Taro Pharmaceutical Industries Ltd expected to post earnings of 84cents a share - Earnings Preview
Brief: Taro Pharmaceuticals Inc. Issues Voluntary Type I Recall Of Taro-Zoledronic Acid Injection, 5 Mg/100 Ml, 100 Ml Vial Due To Particulate Matter Over Specified Requirements
Japan's Kishida likely to retain finance minister in reshuffle - sources (updated)
Taro Pharmaceutical Industries Ltd reports results for the quarter ended in June - Earnings Summary
Taro Pharmaceutical Industries Ltd expected to post earnings of 85 cents a share - Earnings Preview